Markus Weiler

SD-208, a Novel Transforming Growth Factor β Receptor I Kinase Inhibitor, Inhibits Growth and Invasiveness and Enhances Immunogenicity of Murine and Human Glioma Cells<b><i>In vitro</i></b>and<b><i>In vivo</i></b>

Martin Uhl, Steffen Aulwurm, Jörg Wischhusen et al. · Cancer Research · 2004 · 410 citations · Full text

Nusinersen in adults with 5q spinal muscular atrophy: a non-interventional, multicentre, observational cohort study

Tim Hagenacker, Claudia D. Wurster, René Günther et al. · The Lancet Neurology · 2020 · 345 citations · Full text

RNA Interference Targeting Transforming Growth Factor-β Enhances NKG2D-Mediated Antiglioma Immune Response, Inhibits Glioma Cell Migration and Invasiveness, and Abrogates Tumorigenicity<b><i>In vivo</i></b>

Manuel A. Friese, Jörg Wischhusen, Wolfgang Wick et al. · Cancer Research · 2004 · 293 citations

Prognostic or predictive value of <i>MGMT</i> promoter methylation in gliomas depends on <i>IDH1</i> mutation

Wolfgang Wick, Christoph Meisner, Bettina Hentschel et al. · Neurology · 2013 · 227 citations · Full text

mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy

Markus Weiler, Jonas Blaes, Stefan Pusch et al. · Proceedings of the National Academy of Sciences · 2013 · 195 citations · Full text